AI assistant
BALCHEM CORP — Director's Dealing 2025
Dec 5, 2025
31041_dirs_2025-12-05_9c71a65b-3f2c-4e56-a9e3-b1b69e2c9073.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2025-12-03
Reporting Person: Fischer David B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-03 | Common Stock | M | 3383 | $74.57 | Acquired | 13372 | Direct |
| 2025-12-03 | Common Stock | M | 2617 | $84.09 | Acquired | 15989 | Direct |
| 2025-12-03 | Common Stock | S | 6000 | $153.9096 | Disposed | 9989 | Direct |
| 2025-12-03 | Common Stock | S | 2000 | $154.1453 | Disposed | 7989 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-03 | Stock Options | $74.57 | M | 3383 | Disposed | 2028-02-15 | Common Stock (3383) | Direct |
| 2025-12-03 | Stock Options | $84.09 | M | 2617 | Disposed | 2029-02-13 | Common Stock (2617) | Direct |
Footnotes
F1: Exercise of fully vested non-qualified stock options.
F2: This transaction was executed in multiple sales ranging from $153.5100 to $154.2400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F3: This transaction was executed in multiple sales ranging from $153.9045 to $154.3400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F4: Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.
F5: Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.